Infliximab: An effective rescue therapy in refractory extra-pulmonary sarcoidosis

R. R. Abdullah, A. U. Wells, E. A. Renzoni, N. Morar, T. M. Maher, G. J. Keir (London, United Kingdom)

Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Session: Sarcoidosis and other granulomatosis
Session type: Thematic Poster Session
Number: 3792
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. R. Abdullah, A. U. Wells, E. A. Renzoni, N. Morar, T. M. Maher, G. J. Keir (London, United Kingdom). Infliximab: An effective rescue therapy in refractory extra-pulmonary sarcoidosis. Eur Respir J 2013; 42: Suppl. 57, 3792

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Unusual multisystemic relapse of sarcoidosis after corticosteroids withdrawal
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013


Methotrexate as a single agent for the treatment of patients with progressive pulmonary sarcoidosis
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015


Rituximab in the treatment of refractory pulmonary sarcoidosis
Source: Eur Respir J 2014; 43: 1525-1528
Year: 2014


Corticosteroid treatment in sarcoidosis
Source: Eur Respir J 2006; 28: 627-636
Year: 2006



Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis
Source: Eur Respir J 2011; 38: 1145-1150
Year: 2011



Role of infliximab in managing resistant ventricular arrhythmias in sarcoidosis
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015

Infliximab in extrapulmonary sarcoidosis: tantalising but inconclusive
Source: Eur Respir J 2008; 31: 1148-1149
Year: 2008


Anti-TNF-alpha therapy in patients with latent tuberculosis incidence
Source: International Congress 2015 – Screening strategies in TB
Year: 2015

Are there any predictors of MTX response in progressive pulmonary sarcoidosis?
Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Year: 2015

Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial
Source: Eur Respir J 2008; 31: 1189-1196
Year: 2008



Rifamycin induced leukocytoclastic vasculitis. A rare side-effect of anti-tuberculous chemotherapy
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016

Sarcoidosis relapses in corticosteroid treated patients
Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura
Year: 2012



Infliximab in patients with refractory sarcoidosis: Trough concentrations of infiximab
Source: International Congress 2015 – Clinical problems in acute and chronic lung diseases
Year: 2015

Sarcoidosis
Source: Respipedia Article
Year: 2017

Efficacy and safety of modified anti-tubercular treatment(ATT) regimens in treatment of tuberculosis(TB) in patients with underlying chronic liver disease(CLD)
Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline
Year: 2016



Idiopathic pulmonary fibrosis: efficacy of complex immunosuppressive therapy by cyclophosphamide and corticosteroids
Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Year: 2009

Infliximab for treating sarcoidosis, portuguese experience
Source: Annual Congress 2009 - Sarcoidosis in review
Year: 2009


Standard therapy for sarcoidosis
Source: Annual Congress 2005 - Biological agents in the therapy of sarcoidosis
Year: 2005

Therapeutic options for sarcoidosis: old and new
Source: Annual Congress 2005 - PG15 - Therapeutic options for interstitial lung diseases in 2005
Year: 2005